DG
ELV icon

Davidson & Garrard’s Elevance Health ELV Stock Holding History

Davidson & Garrard’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$515K Hold
2,711
– – 0.12% 127
2017
Q2 		$510K Sell
2,711
-300
-10% -$53.9K 0.12% 132
2017
Q1 		$498K Hold
3,011
– – 0.12% 129
2016
Q4 		$433K Sell
3,011
-313
-9% -$41.9K 0.11% 130
2016
Q3 		$417K Hold
3,324
– – 0.1% 133
2016
Q2 		$437K Buy
3,324
+638
+24% +$87.3K 0.11% 140
2016
Q1 		$373K Buy
2,686
+961
+56% +$128K 0.1% 134
2015
Q4 		$241K Hold
1,725
– – 0.06% 165
2015
Q3 		$242K Buy
1,725
+100
+6% +$15K 0.06% 161
2015
Q2 		$267K Hold
1,625
– – 0.06% 167
2015
Q1 		$251K Hold
1,625
– – 0.06% 165
2014
Q4 		$204K Buy
+1,625
New +$201K 0.05% 174

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Davidson & Garrard's ELV Position: Q3 2017 in Review

Davidson & Garrard held its Elevance Health (ELV) position steady in Q3 2017 at 2,711 shares worth $515K. The position accounts for 0.12% of the portfolio, ranked #127.

Davidson & Garrard first reported a position in ELV in Q4 2014 and has held it in 12 quarters since. 844 funds tracked by Wall St. Rank hold ELV as of Q3 2017.

  • Davidson & Garrard held 2,711 shares of Elevance Health worth $515K as of Q3 2017.
  • Davidson & Garrard left its Elevance Health share count unchanged in Q3 2017.
  • Elevance Health made up 0.12% of Davidson & Garrard's portfolio in Q3 2017, its #127 holding.
  • Davidson & Garrard first reported a position in Elevance Health in Q4 2014 and has held it in 12 quarters since.
  • 844 funds tracked by Wall St. Rank held Elevance Health as of Q3 2017.

Based on Davidson & Garrard's 13F filing for Q3 2017, filed 7 Nov 2017.